Sex- and Age Group-Specific Fracture Incidence Rates Trends for Type 1 and 2 Diabetes Mellitus.

FRACTURES INCIDENCE TRENDS TYPE 1 DIABETES MELLITUS TYPE 2 DIABETES MELLITUS

Journal

JBMR plus
ISSN: 2473-4039
Titre abrégé: JBMR Plus
Pays: England
ID NLM: 101707013

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 26 06 2023
revised: 14 09 2023
accepted: 01 10 2023
medline: 29 11 2023
pubmed: 29 11 2023
entrez: 29 11 2023
Statut: epublish

Résumé

The incidence of major osteoporotic fractures has declined in men and women in Western countries over the last two decades. Although fracture risk is higher in persons with diabetes mellitus, trends of fractures remain unknown in men and women with diabetes. We investigated the trends in fracture incidence rates (IRs) in men and women with type 1 diabetes mellitus (T1D) and type 2 diabetes mellitus (T2D) in Denmark between 1997 and 2017. We identified men and women aged 18+ years who sustained a fracture (excluding skull and facial fractures) between 1997 and 2017 using the Danish National Patient Registry. We calculated sex-specific IRs of fractures per 10,000 person-years separately in persons with T1D, T2D, or without diabetes. Furthermore, we compared median IRs of the first 5 years (1997-2002) to the median IRs of the last 5 years (2012-2017). We identified 1,235,628 persons with fractures including 4863 (43.6% women) with T1D, 65,366 (57.5% women) with T2D, and 1,165,399 (54.1% women) without diabetes. The median IRs of fractures declined 20.2%, 19.9%, and 7.8% in men with T1D, T2D, and without diabetes, respectively (

Identifiants

pubmed: 38025040
doi: 10.1002/jbm4.10836
pii: JBM410836
pmc: PMC10652176
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e10836

Informations de copyright

© 2023 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.

Références

Bone. 2016 Jan;82:2-8
pubmed: 26027505
Diabetes Care. 2001 Jul;24(7):1198-203
pubmed: 11423502
JAMA. 2009 Feb 4;301(5):513-21
pubmed: 19190316
Lancet. 2013 Nov 2;382(9903):1507-13
pubmed: 23849796
Curr Osteoporos Rep. 2020 Dec;18(6):737-758
pubmed: 33165875
Bone. 2020 Aug;137:115457
pubmed: 32480023
Bone. 2014 Nov;68:115-23
pubmed: 25173606
Endocrinol Metab Clin North Am. 2020 Dec;49(4):667-678
pubmed: 33153673
Diabetes Care. 2023 Mar 1;46(3):633-642
pubmed: 36696428
Diabet Med. 2012 Aug;29(8):e176-9
pubmed: 22506989
Osteoporos Int. 2019 Nov;30(11):2217-2223
pubmed: 31418061
Diabetes Obes Metab. 2012 Nov;14(11):990-9
pubmed: 22651373
Scand J Public Health. 2019 Aug;47(6):611-617
pubmed: 29886814
Lancet. 2009 Oct 3;374(9696):1196-208
pubmed: 19801098
Diabetes Care. 2007 Feb;30(2):389-94
pubmed: 17259518
Bone. 2019 Mar;120:476-481
pubmed: 30583122
Osteoporos Int. 2018 Dec;29(12):2639-2644
pubmed: 30083774
JAMA. 2009 Oct 14;302(14):1573-9
pubmed: 19826027
Curr Osteoporos Rep. 2022 Dec;20(6):398-409
pubmed: 36190648
Curr Osteoporos Rep. 2019 Jun;17(3):147-156
pubmed: 30915638
Diabetes Res Clin Pract. 2014 Aug;105(2):217-22
pubmed: 24928339
Diabetes Care. 2002 Oct;25(10):1749-54
pubmed: 12351472
Lancet Diabetes Endocrinol. 2022 Mar;10(3):207-220
pubmed: 35101185
J Bone Miner Res. 2023 Aug;38(8):1064-1075
pubmed: 37118993
Diabetes Care. 2020 Jan;43(1):137-144
pubmed: 31658976
Diabetes. 2012 Nov;61(11):2987-92
pubmed: 22851572
Br J Ophthalmol. 2017 Oct;101(10):1346-1351
pubmed: 28270484
Osteoporos Int. 2010 Mar;21(3):373-80
pubmed: 19436931
J Bone Miner Res. 2004 Jul;19(7):1084-91
pubmed: 15176990
Diabetes Obes Metab. 2023 Apr;25(4):1002-1010
pubmed: 36514856
Calcif Tissue Int. 2017 Feb;100(2):109-121
pubmed: 27444009
Clin Epidemiol. 2016 Oct 14;8:381-387
pubmed: 27789974
Osteoporos Int. 2003 Jan;14(1):69-76
pubmed: 12577187
Bone. 2017 Feb;95:136-142
pubmed: 27890548
Clin Drug Investig. 2006;26(7):367-401
pubmed: 17163272
Clin Endocrinol (Oxf). 2018 Sep;89(3):314-323
pubmed: 29876960
J Gerontol A Biol Sci Med Sci. 2013 Oct;68(10):1243-51
pubmed: 23902935
Osteoporos Int. 2007 Apr;18(4):427-44
pubmed: 17068657
Curr Drug Saf. 2021;16(1):52-61
pubmed: 32900349
Acta Obstet Gynecol Scand. 2007;86(11):1342-51
pubmed: 17963062
World J Diabetes. 2015 Jul 10;6(7):912-26
pubmed: 26185599
J Osteoporos. 2015;2015:717914
pubmed: 26295003
Am J Epidemiol. 2002 Jul 1;156(1):1-10
pubmed: 12076883

Auteurs

Mohamad I Nasser (MI)

Department of Endocrinology and Metabolism, Molecular Endocrinology Stem Cell Research Unit (KMEB) Odense University Hospital Odense Denmark.
Department of Clinical Research University of Southern Denmark Odense Denmark.
Steno Diabetes Center Odense Odense University Hospital Odense Denmark.

Annika Vestergaard Kvist (AV)

Department of Endocrinology and Metabolism, Molecular Endocrinology Stem Cell Research Unit (KMEB) Odense University Hospital Odense Denmark.
Department of Clinical Research University of Southern Denmark Odense Denmark.
Pharmacoepidemiology Group, Institute of Pharmaceutical Sciences ETH Zurich Zurich Switzerland.
Steno Diabetes Center North Denmark Aalborg University Hospital Aalborg Denmark.

Peter Vestergaard (P)

Steno Diabetes Center North Denmark Aalborg University Hospital Aalborg Denmark.
Department of Endocrinology Aalborg University Hospital Aalborg Denmark.
Department of Clinical Medicine Aalborg University Hospital Aalborg Denmark.

Richard Eastell (R)

Academic Unit of Bone Metabolism University of Sheffield Sheffield UK.
Mellanby Centre for Musculoskeletal Research University of Sheffield Sheffield UK.

Andrea M Burden (AM)

Pharmacoepidemiology Group, Institute of Pharmaceutical Sciences ETH Zurich Zurich Switzerland.
Leslie Dan Faculty of Pharmacy University of Toronto Toronto Canada.

Morten Frost (M)

Department of Endocrinology and Metabolism, Molecular Endocrinology Stem Cell Research Unit (KMEB) Odense University Hospital Odense Denmark.
Department of Clinical Research University of Southern Denmark Odense Denmark.
Steno Diabetes Center Odense Odense University Hospital Odense Denmark.

Classifications MeSH